Skip to main content
$79.46 -$0.30 (-0.4%)

10:27 AM EDT on 08/14/20

Axsome Therapeutics, Inc. (NASDAQ:AXSM)

CAPS Rating: 2 out of 5

Current Price $79.46 Mkt Cap $2.9B
Open $79.68 P/E Ratio 0.00
Prev. Close $79.76 Div. (Yield) $0.00 (0.0%)
Daily Range $78.69 - $79.85 Volume 59,298
52-Wk Range $13.64 - $109.94 Avg. Daily Vol. 492,675

Caps

How do you think NASDAQ:AXSM will perform against the market?

Add Stock to CAPS Watchlist

All Players

47 Outperform
18 Underperform
 

All-Star Players

11 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AXSM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

drterry (65.68)
Submitted May 08, 2020

They have come up with a technology to cross blood brain barrier with better funcitonality of an antidepressant and medicine for agitation in Alzheimer's. With Alzheimer's cases increasing, having a way to help with agitation without sedating the… More

SmartAce (99.98)
Submitted December 26, 2018

Sometimes, during the movie previews, I'll turn to the stranger sitting next to me and whisper, "We should really go see that together."

NASDAQ:AXSM VS S&P 500 (SPY)

NASDAQ:AXSM Summary

Fools bearish on NASDAQ:AXSM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AXSM.

Recs

0
Member Avatar Dmikada (36.32) Submitted: 7/27/2020 3:53:13 PM : Outperform Start Price: $79.26 NASDAQ:AXSM Score: -3.72

Biotech company stock dropped due to company does not participate in the Covid vaccine race. They should be really successful after their anti-depression drugs are approved

Recs

0
Member Avatar Wittgenstein7 (< 20) Submitted: 7/20/2020 6:36:59 PM : Outperform Start Price: $82.43 NASDAQ:AXSM Score: -6.37

Sound performance in phase III (difficult to achieve by antidepressant drugs) Combination of well known drugs, so limited downside due to new adverse events. 3x FDA Fasttrack status.

Recs

1
Member Avatar drterry (65.68) Submitted: 5/8/2020 1:27:46 AM : Outperform Start Price: $92.00 NASDAQ:AXSM Score: -28.86

They have come up with a technology to cross blood brain barrier with better funcitonality of an antidepressant and medicine for agitation in Alzheimer's. With Alzheimer's cases increasing, having a way to help with agitation without sedating the patients would allow them to stay home longer rather than be institutionalized, and reduce falls.

Leaderboard

Find the members with the highest scoring picks in AXSM.

Score Leader

jeepdrew222

jeepdrew222 (83.46) Score: +2,951.21

The Score Leader is the player with the highest score across all their picks in AXSM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jeepdrew222 83.46 8/27/2018 Outperform 5Y $2.60 +2,967.69% +16.48% +2,951.21 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 46.19 2/9/2018 Outperform 5Y $2.60 +2,967.69% +29.01% +2,938.68 0 Comment
NextGenStock 36.46 6/20/2018 Outperform 5Y $3.00 +2,558.67% +21.79% +2,536.88 0 Comment
NateVDM214 < 20 6/21/2018 Outperform 3Y $3.15 +2,432.06% +21.92% +2,410.14 0 Comment
jumbofaceplate 41.20 5/15/2017 Outperform 5Y $4.10 +1,845.37% +40.50% +1,804.86 0 Comment
ababrmon 86.97 1/2/2018 Outperform 5Y $5.47 +1,358.46% +25.41% +1,333.05 0 Comment
warmwind < 20 1/13/2017 Outperform 5Y $5.50 +1,350.18% +48.40% +1,301.79 0 Comment
clangmead 51.14 1/15/2019 Outperform 5Y $7.52 +960.64% +30.50% +930.14 0 Comment
Momentum21 65.23 6/2/2016 Outperform 5Y $7.68 +938.54% +60.03% +878.51 0 Comment
portefeuille 98.76 1/8/2019 Outperform 5Y $8.11 +883.48% +31.01% +852.47 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AXSM.